GNMX holdings

All 59 positions of Corgi Genomics & Precision Medicine ETF. as of Oct 21, 2026issuer data

Positions
59
Top 10 weight
49.0%
Effective holdings
25.2
1 / sum of squared weights
In stocks
97.5%
In bonds
0.0%
Outside the US
6.6%

Asset mix

  • Equity97.5%
  • Cash2.5%

Sectors

100% of stocks classified
  • Health Care74.7%
  • Technology20.7%
  • Industrials2.2%

Countries

  • United States90.9%
  • Denmark3.2%
  • Netherlands2.9%
  • Switzerland0.6%

Holdings

as of Oct 21, 2026issuer data
#HoldingTypeWeightValueShares / parCountry
1MRNAModerna, Inc. Common StockEquity10.77%$143K581US
2TMOThermo Fisher Scientific, Inc.Equity8.79%$117K168US
3VRTXVertex Pharmaceuticals IncEquity5.82%$77K147US
4ILMNIllumina IncEquity4.93%$65K231US
5GHGuardant Health, Inc. Common StockEquity3.43%$45K273US
6TXG10x Genomics, Inc. Class A Common StockEquity3.23%$43K567US
7GMABGenmab A/S ADSEquity3.18%$42K1,064DK
8RVMDRevolution Medicines, Inc. Common StockEquity3.18%$42K217US
9IOVAIovance Biotherapeutics, Inc. Common StockEquity3.14%$42K2,849US
10INCYIncyte Genomics IncEquity2.52%$33K294US
11First American Government Obligations Fund 12/01/2031Cash2.50%$33K33,207
12TWSTTwist Bioscience Corporation Common StockEquity2.44%$32K217US
13ALNYAlnylam Pharmaceuticals, Inc.Equity2.38%$32K140US
14TECHBio-Techne Corp.Equity2.11%$28K385US
15GRALGRAIL, Inc. Common StockEquity2.10%$28K210US
16QGENQIAGEN N.V.Equity2.06%$27K546NL
17CDNACareDx, Inc.Equity2.02%$27K378US
18BMRNBioMarin Pharmaceuticals IncEquity1.84%$24K441US
19KRYSKrystal Biotech, Inc. Common StockEquity1.70%$23K70US
20TEMTempus AI, Inc. Class A Common StockEquity1.68%$22K329US
21ADPTAdaptive Biotechnologies Corporation Common StockEquity1.58%$21K826US
22CAICaris Life Sciences, Inc. Common StockEquity1.37%$18K560US
23NEONeoGenomics, Inc.Equity1.31%$17K1,022US
24VCYTVeracyte, Inc.Equity1.29%$17K371US
25ARWRArrowhead Research CorporationEquity1.27%$17K287US
26CRSPCRISPR Therapeutics AGEquity1.25%$17K329US
27NRIXNurix Therapeutics, Inc. Common stockEquity1.24%$16K630US
28PSNLPersonalis, Inc. Common StockEquity1.19%$16K994US
29IDYAIDEAYA Biosciences, Inc. Common StockEquity1.16%$15K434US
30ABSIAbsci Corporation Common StockEquity1.15%$15K1,519US
31SDGRSchrodinger, Inc. Common StockEquity1.15%$15K637US
32IONSIonis Pharmaceuticals, Inc. Common StockEquity1.12%$15K336US
33RLAYRelay Therapeutics, Inc. Common StockEquity0.98%$13K707US
34CERTCertara, Inc. Common StockEquity0.89%$12K1,155US
35AZTAAzenta, Inc.Equity0.87%$12K315US
36BEAMBeam Therapeutics Inc. Common StockEquity0.84%$11K448US
37SRPTSarepta Therapeutics,, Inc. Common StockEquity0.82%$11K588US
38RXRXRecursion Pharmaceuticals, Inc. Class A Common StockEquity0.81%$11K2,968US
39QUREuniQure N.V.Equity0.81%$11K476NL
40CSTLCastle Biosciences, Inc. Common StockEquity0.76%$10K294US
41WGSGeneDx Holdings Corp. Class A Common StockEquity0.73%$10K140US
42NTLAIntellia Therapeutics, IncEquity0.66%$9K749US
43FDMT4D Molecular Therapeutics, Inc. Common StockEquity0.63%$8K665US
44PACBPacific Biosciences of California, Inc.Equity0.60%$8K3,724US
45GENBGenerate Biomedicines, Inc. Common StockEquity0.58%$8K588US
46RAREUltragenyx Pharmaceutical Inc.Equity0.57%$8K476US
47SOPHSOPHiA GENETICS SA Ordinary SharesEquity0.55%$7K987CH
48BDSXBiodesix, Inc. Common StockEquity0.53%$7K294US
49MYGNMyriad Genetics IncEquity0.51%$7K1,225US
50FLGTFulgent Genetics, Inc. Common StockEquity0.50%$7K329US
51PRMEPrime Medicine, Inc. Common StockEquity0.44%$6K1,519US
52SLDBSolid Biosciences Inc. Common StockEquity0.43%$6K889US
53ARCTArcturus Therapeutics Holdings Inc. Common StockEquity0.42%$6K504US
54EDITEditas Medicine, Inc. Common StockEquity0.31%$4K1,638US
55LABStandard BioTools Inc. Common StockEquity0.27%$4K5,439US
56DTILPrecision BioSciences, Inc. Common StockEquity0.27%$4K525US
57RCKTRocket Pharmaceuticals, Inc. Common StockEquity0.25%$3K1,491US
58CRBUCaribou Biosciences, Inc. Common StockEquity0.08%$1K1,946US
59Cash & OtherCash-0.02%−$248-248

Find which other funds hold a stock by opening it and choosing "ETFs holding".

Fund data comes from each fund's SEC filings and issuer disclosures and is shown with the date it is as of. SEC portfolio and flow filings become public about 60 days after the period they cover. Nothing here is investment advice; see Terms.